-
GLYCOPAR – A randomized, placebo-controlled, 2-arm parallel-group superiority phase II study of glycopyrrolate for moderate-to-severe sialorrhea in Parkinson’s disease
-
Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease
-
Glymphatic system activity in Parkinson’s disease: diffusion tensor image analysis along the perivascular space (DTI‑ALPS)
-
GNAO1 gene mutation: generalized dystonia without epilepsy.
-
Goal setting for botulinum toxin injections: Impact of the Upper Limb International Spasticity (ULIS) programme
-
Gocovri Dose Adjustment in Elderly Parkinson’s Patients at Risk for Renal Impairment: Implications from an Exposure Simulation Model
-
GPi DBS does not affect sensory thresholds in hereditary/idiopathic dystonia
-
Gray Matter Abnormalities in Parkinson’s disease: a Voxel-wise meta-analysis
-
Gray matter atrophy in Parkinson’s disease and freezing of gait assessed using surface-based algorithm – results of an open, longitudinal, single-centre study
-
Gray matter substrates of depression in blepharospasm
- « Previous Page
- 1
- …
- 90
- 91
- 92
- 93
- 94
- …
- 217
- Next Page »